Mohammed Moustapha Anwar

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Venues

Cancer cell international

Scientific reports

The Journal of the Egyptian Public Health Association

Inflammation

CL MENA Region

This page only lists publications with an associated author ORCID identifier.

Affiliation History

CL MENA Region Jan 01 2017 - Aug 31 2019

Egypt

Medical Advisory Manager :: Medical

Publications

Nermin A Osman, Mohammed Moustapha Anwar, Bivek Singh, Girish K Gupta, Amgad M Rabie
A peek behind the curtain in the diagnosis and management of COVID‑19‑Associated Mucormycosis (CAM). The Journal of the Egyptian Public Health Association 98 (1) (2023)
Nermin A Osman, Mohammed Moustapha Anwar, Bivek Singh, Girish K Gupta, Amgad M Rabie
A peek behind the curtain in the diagnosis and management of COVID‑19‑Associated Mucormycosis (CAM). The Journal of the Egyptian Public Health Association 98 (1) (2023)
Mohammed Moustapha Anwar, Ranjit Sah, Sunil Shrestha, Akihiko Ozaki, Namrata Roy, Zareena Fathah, Alfonso Javier Rodriguez-Morales
Disengaging the COVID-19 Clutch as a Discerning Eye Over the Inflammatory Circuit During SARS-CoV-2 Infection. Inflammation 45 (5) (2022)
Mohammed Moustapha Anwar, Chris Albanese, Nadia M Hamdy, Ahmed S Sultan
Rise of the natural red pigment 'prodigiosin' as an immunomodulator in cancer. Cancer cell international 22 (1) (2022)
Mohammed Moustapha Anwar, Chris Albanese, Nadia M Hamdy, Ahmed S Sultan
Rise of the natural red pigment 'prodigiosin' as an immunomodulator in cancer. Cancer cell international 22 (1) (2022)
Mohammed Moustapha Anwar, Manal Aly Shalaby, Hesham Saeed, Haitham Mohammed Mostafa, Dalia Galal Hamouda, Howaida Nounou
Theophylline-encapsulated Nile Tilapia fish scale-based collagen nanoparticles effectively target the lungs of male Sprague-Dawley rats. Scientific reports 12 (1) (2022)
Mohammed Moustapha Anwar, Chris Albanese, Nadia M Hamdy, Ahmed S Sultan
Rise of the natural red pigment 'prodigiosin' as an immunomodulator in cancer. Cancer cell international 22 (1) (2022)
Mohammed Moustapha Anwar, Manal Shalaby, Amira M Embaby, Hesham Saeed, Mona M Agwa, Ahmed Hussein
Prodigiosin/PU-H71 as a novel potential combined therapy for triple negative breast cancer (TNBC): preclinical insights. Scientific reports 10 (1) (2020)

Mohammed Moustapha Anwar.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mohammed Moustapha Anwar